Navigation Links
Studies Show That TSH Is Unreliable in the Diagnosis of Hypothyroidism According to Article Contributed by Kent Holtorf, M.D. in Clinical Geriatrics
Date:1/3/2012

LOS ANGELES, Jan. 3, 2012 /PRNewswire/ -- TSH testing, the gold standard in hypothyroid diagnosis, may be misleading according to the studies quoted in a new article titled Hormone Replacement Therapy in the Geriatric Patient: Current State of the Evidence and Questions for the Future. Estrogen, Progesterone, Testosterone, and Thyroid Hormone Augmentation in Geriatric Clinical Practice. The article, independently written and published, is a broad study of hormone replacement in geriatric patients. In the thyroid section, written by Kent Holtorf M.D., it details the difference between serum thyroid hormone levels and tissue thyroid hormone levels, particularly in cases of chronic and acute stress.

According to the study models presented in the article, physiological stress, caused by aging or illness, means patients can present with typical hypothyroid symptoms but with serum testing that shows normal TSH and even T3. "As a result, when relying on serum tests only, clinicians do not treat patients presenting with this thyroid picture assuming they are euthyroid," reads the article. However, those same patients may be experiencing diminished T3 levels within the peripheral tissues, due to reactive changes at the cellular level. According to the authors, this leaves "a gaping hole" and misses "the opportunity to help the patients' condition."

The article also addresses the possible benefits of marking reverse T3 levels in serum testing as a means of determining the overall health of the "hypothalamic–pituitary–thyroid– cellular axis," and it warns of the suppression of TSH serum levels in some patients with nonthyroidal illness or who are on medication. This kind of "confusion" only serves to undermine further the reliability of standard thyroid testing.

The article concludes with a summary of treatment options, citing T3 preparations as more effective in cases of chronic or age-related stress. "Many symptomatic patients with low tissue thyroid levels with normal TSH and T4 levels may benefit from T3 thyroid replacement, often with significant improvement in fatigue, depression, weight gain and obesity, heart failure, fibromyalgia, cholesterol levels, and numerous other chronic conditions." Additionally, some of the long-held fears of significant side effects associated with hormone supplementation may be overstated.

KENT HOLTORF, MD: Dr. Holtorf is the founding director of the Bioidentical Hormone Initiative as well as the National Academy of Hypothyroidism  and the medical director of the Holtorf Medical Group, Center for Hormone Imbalance, Hypothyroidism, and Fatigue, located in Los Angeles, Pasadena and Foster City, CA and Philadelphia, PA. He founded the Holtorf Medical Group in 2001 and continues to treat patients from across the country and abroad. His full profile can be viewed at www.holtorfmed.com

CONTACT: Jeny Kherkher, +1-310-375-2705, jenyk@holtorfmed.com


 


'/>"/>
SOURCE Holtorf Medical Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec®
2. Studies Investigate New Methodologies to Improve Recovery and Survival Strategies for Patients Undergoing Hematopoietic Cell Transplantation
3. Bayers Drospirenone-containing Combination Oral Contraceptives: FDA Advisory Committees Affirm Positive Benefit-risk Profile and Recommend an Update of Labels to Reflect Information From Available Studies
4. Genomic Health Announces Presentation of Sixteen Oncotype DX Studies at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
5. Montage Announces Three More Hospitals Implement Their On-Demand Search and Data Mining Technology for Radiology Studies
6. Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types
7. Isis Initiates Phase 1 Studies with Isis-GCGRRx and Isis-GCCRRx to Treat Type 2 Diabetes
8. Data From Phase 2 Clinical Studies of Telotristat Etiprate in Patients With Carcinoid Syndrome to be Presented at North American Neuroendocrine Tumor Society Meeting
9. New Clinical Studies Presented at the American Society of Anesthesiologists Annual Meeting Show Benefits of Masimo Noninvasive Technologies: SpHb, PVI, RRa, and SEDLine
10. Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
11. Managing Bioequivalence Studies to Optimize the Quality, Cost, and Speed of Generics Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology:
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):